• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物多糖HS-142-1竞争性且选择性地抑制心钠素与其含鸟苷酸环化酶的受体的结合。

Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor.

作者信息

Morishita Y, Sano T, Ando K, Saitoh Y, Kase H, Yamada K, Matsuda Y

机构信息

Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Japan.

出版信息

Biochem Biophys Res Commun. 1991 May 15;176(3):949-57. doi: 10.1016/0006-291x(91)90374-g.

DOI:10.1016/0006-291x(91)90374-g
PMID:1674870
Abstract

During the search for ANP receptor ligands of microbial origin, we isolated a novel polysaccharide, HS-142-1, from culture broth of Aureobasidium sp. HS-142-1 inhibited [125I]-rANP binding to ANP receptor in rabbit kidney cortex membranes with an IC50 of 0.3 mu g/ml, but gave no effects on specific binding of [125I]-Endothelin nor [125I]-Angiotensin II to their respective receptors in bovine lung membranes. HS-142-1 competitively and selectively inhibited ANP binding to its guanylyl cyclase-containing receptor purified from solubilized bovine adrenocortical membranes and blocked cGMP production elicited by ANP. HS-142-1 is the first non-peptide antagonist selective for ANP functional receptor and will be a powerful tool to elucidate the physiological functions of ANP.

摘要

在寻找微生物来源的心房钠尿肽(ANP)受体配体的过程中,我们从 Aureobasidium sp. 的培养液中分离出一种新型多糖 HS - 142 - 1。HS - 142 - 1 抑制 [125I] - rANP 与兔肾皮质膜中 ANP 受体的结合,IC50 为 0.3 μg/ml,但对 [125I] - 内皮素或 [125I] - 血管紧张素 II 与牛肺膜中各自受体的特异性结合没有影响。HS - 142 - 1 竞争性且选择性地抑制 ANP 与从溶解的牛肾上腺皮质膜中纯化的含鸟苷酸环化酶受体的结合,并阻断 ANP 引发的环磷酸鸟苷(cGMP)生成。HS - 142 - 1 是首个对 ANP 功能受体具有选择性的非肽拮抗剂,将成为阐明 ANP 生理功能的有力工具。

相似文献

1
Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor.微生物多糖HS-142-1竞争性且选择性地抑制心钠素与其含鸟苷酸环化酶的受体的结合。
Biochem Biophys Res Commun. 1991 May 15;176(3):949-57. doi: 10.1016/0006-291x(91)90374-g.
2
HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist, blocks ANP-induced renal responses through a specific interaction with guanylyl cyclase-linked receptors.HS-142-1是一种新型非肽类心房利钠肽(ANP)拮抗剂,它通过与鸟苷酸环化酶连接受体的特异性相互作用来阻断ANP诱导的肾脏反应。
Eur J Pharmacol. 1992 Mar 12;225(3):203-7. doi: 10.1016/0922-4106(92)90021-m.
3
Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors.HS-142-1(一种新型的源自微生物的非肽类心房利钠肽拮抗剂)通过阻断鸟苷酸环化酶连接受体,抑制心房利钠肽诱导的离体兔主动脉舒张。
Mol Pharmacol. 1992 Dec;42(6):982-90.
4
HS-142-1, a novel polysaccharide of microbial origin, specifically recognizes guanylyl cyclase-linked ANP receptor in rat glomeruli.HS-142-1是一种新型的微生物来源多糖,它能特异性识别大鼠肾小球中与鸟苷酸环化酶相连的心房钠尿肽受体。
Life Sci. 1992;51(18):1445-51. doi: 10.1016/0024-3205(92)90539-2.
5
Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.HS-142-1的药理学特性,一种新型的微生物来源的非肽类心房利钠肽拮抗剂。I. 对麻醉大鼠中利钠肽作用的选择性抑制
J Pharmacol Exp Ther. 1992 Feb;260(2):825-31.
6
Bovine adrenal medullary cells contain functional atrial natriuretic peptide receptors.
Biochem Biophys Res Commun. 1988 Jan 29;150(2):781-7. doi: 10.1016/0006-291x(88)90459-7.
7
Copurification of atrial natriuretic factor receptors and guanylyl cyclase from adrenal cortex.
Methods Enzymol. 1991;195:404-13. doi: 10.1016/0076-6879(91)95187-o.
8
Stable expression of natriuretic peptide receptors: effects of HS-142-1, a non-peptide ANP antagonist.利钠肽受体的稳定表达:非肽类心房钠尿肽拮抗剂HS-142-1的作用
Biochem Biophys Res Commun. 1992 Nov 30;189(1):336-42. doi: 10.1016/0006-291x(92)91563-6.
9
The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis.H295R人肾上腺皮质细胞系含有可抑制醛固酮生物合成的功能性心钠素受体。
Mol Cell Endocrinol. 1996 Apr 19;118(1-2):137-44. doi: 10.1016/0303-7207(96)03776-8.
10
A linear analog of atrial natriuretic peptide (ANP) discriminates guanylate cyclase-coupled ANP receptors from non-coupled receptors.
J Biol Chem. 1988 Aug 5;263(22):10989-93.

引用本文的文献

1
Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch.干预 B 型利钠肽信号通路作为控制慢性瘙痒的一种手段。
Br J Pharmacol. 2020 Mar;177(5):1025-1040. doi: 10.1111/bph.14952. Epub 2020 Feb 12.
2
The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.《2013/14药理学简明指南:催化受体》
Br J Pharmacol. 2013 Dec;170(8):1676-705. doi: 10.1111/bph.12449.
3
Natriuretic peptide receptors and heart failure: to B or not to B blocked?利钠肽受体与心力衰竭:是否阻断B型利钠肽受体?
Naunyn Schmiedebergs Arch Pharmacol. 2014 Jan;387(1):1-4. doi: 10.1007/s00210-013-0946-0. Epub 2013 Dec 6.
4
Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes.血管钠肽,脂肪细胞中脂联素和白细胞介素-6 产生的新调节剂。
J Endocrinol Invest. 2011 Nov;34(10):742-6. doi: 10.3275/7727. Epub 2011 May 17.
5
Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.心血管系统中的利钠肽受体B信号传导:预防心脏肥大。
J Mol Med (Berl). 2007 Aug;85(8):797-810. doi: 10.1007/s00109-007-0183-4. Epub 2007 Apr 12.
6
Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.利钠肽受体-C在介导C型利钠肽和内皮衍生超极化因子的血管舒张活性中的决定性作用。
Cardiovasc Res. 2007 Jun 1;74(3):515-25. doi: 10.1016/j.cardiores.2007.02.032. Epub 2007 Mar 3.
7
Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.血管钠尿肽受体相关颗粒型鸟苷酸环化酶受一氧化氮-环鸟苷酸信号通路调节。
Br J Pharmacol. 2003 Aug;139(7):1289-96. doi: 10.1038/sj.bjp.0705365.
8
The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages.心房利钠肽调节巨噬细胞中炎症介质的产生。
Ann Rheum Dis. 2001 Nov;60 Suppl 3(Suppl 3):iii68-70. doi: 10.1136/ard.60.90003.iii68.
9
Allotopic antagonism of the non-peptide atrial natriuretic peptide (ANP) antagonist HS-142-1 on natriuretic peptide receptor NPR-A.非肽类心房利钠肽(ANP)拮抗剂HS-142-1对利钠肽受体NPR-A的异位拮抗作用。
Biochem J. 2002 Feb 15;362(Pt 1):231-7. doi: 10.1042/0264-6021:3620231.
10
The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.肾素-血管紧张素-醛固酮系统与心钠素
Heart. 1996 Nov;76(3 Suppl 3):36-44. doi: 10.1136/hrt.76.3_suppl_3.36.